self-expanding stent


Also found in: Dictionary, Thesaurus, Encyclopedia.

self-expanding stent

A stent that opens on its own after it is deployed to the lumen it is intended to occupy, e.g., a blood vessel, tube, or organ.
See also: stent
References in periodicals archive ?
Edwards Lifesciences also announced the limited launch of the first sizes of its Edwards LifeStent NT Self-Expanding Stent system for use in treating biliary disease.
Of those, 151 patients were treated with the Absolute Pro Peripheral Self-Expanding Stent System (AP), while 153 were treated with the Omnilink Elite Peripheral Balloon-Expandable Stent System (OLE).
The Absolute Pro Peripheral Self-Expanding Stent is currently an investigational device in the United States for the treatment of iliac artery disease.
The addition of the Pulsar-35 self-expanding stent system will make BIOTRONIK s proven stent technology available to even more clinicians offering a convenient platform.
The RESILIENT Trial is a randomized, multi-center study using the flexible LifeStent self-expanding stent in the understudied and challenging SFA region," said Barry T.
Optimal self-expanding stent design specific to the anatomy of the sidebranch, combined with the proprietary delivery system provide a dynamic solution for treating sidebranch disease.
Food and Drug Administration (FDA) approval to market its PRECISE(R) RX Nitinol Self-Expanding Stent and ANGIOGUARD(R) RX Emboli Capture Guidewire System to treat clogged neck arteries.
The clinical results of the Stentys DES in complex lesions have been spectacular, and we are thrilled that patients throughout Europe will have access to the benefits of our self-expanding stent in due course," said Gonzague Issenmann, CEO and co-founder of Stentys.
Food and Drug Administration (FDA) approval for the Innova vascular self-expanding stent system, a treatment option for patients with narrowing or blockages in the superficial femoral artery (SFA) or proximal popliteal artery (PPA).
19, 2015 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received Food and Drug Administration (FDA) approval for the Innova(TM) Vascular Self-Expanding Stent System, an advanced treatment option for patients with narrowing or blockages in the superficial femoral artery (SFA) or proximal popliteal artery (PPA).
The MOBILITY study, a prospective, non-randomized, two-arm, multi-center study conducted at 48 centers in the United States, evaluated the effectiveness of two Abbott stents - Absolute Pro Vascular Self-Expanding Stent System and Omnilink Elite Vascular Balloon-Expandable Stent System - in patients who had iliac artery disease with intermittent claudication or critical limb ischemia, including complex lesions.
The other patients in the study received an intervention of a self-expanding stent that widens a major artery in the brain and facilitates blood flow.